Evidence map›Paper›PMID 35480706›Full record

ArticleCanada communicable disease report = Releve des maladies transmissibles au Canada2022

Antibiotic prescribing for respiratory tract infection across a national primary care network in 2019.

Sabrina Wong, Shan Rajapakshe, David Barber, Andrea Patey, Wendy Levinson, Rachael Morkem, Gillian Hurwitz, Kimberly Wintermute, Jerome A Leis

Open access · diamondAbstract read
In one paragraph

Article in Canada communicable disease report = Releve des maladies transmissibles au Canada, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.9field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 6 institutions in 4 countries.

Sabrina WongUniversity of British Columbia Centre for Health Services and Policy Research and School of Nursing, Vancouver, BC.
Shan RajapaksheIsland Medical Program, Faculty of Medicine, University of British Columbia, Victoria, BC.
David BarberDepartment of Family Medicine, Queen's University, Kingston, ON.
Andrea PateyOttawa Hospital Research Institute, Ottawa, ON.
Wendy LevinsonSt. Michael's Hospital, Toronto, ON.
Rachael MorkemDepartment of Family Medicine, Queen's University, Kingston, ON.
Gillian HurwitzSt. Michael's Hospital, Toronto, ON.
Kimberly WintermuteNorth York General Hospital, Toronto, ON.
Jerome A LeisSunnybrook Health Sciences Centre, Toronto, ON.
Queen's University · CASt Michael’s Hospital · IEUniversity of British Columbia · CANorth York General Hospital · CAOttawa Hospital Research InstituteUniversity of Toronto · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Respiratory tract infection (RTI) is the leading reason for avoidable antimicrobial use in primary care, yet provider-level feedback on its use is only available in some provinces. The aim of this study was to validate case definitions for RTI across the Canadian Primary Care Sentinel Surveillance Network (CPCSSN) and determine baseline provider-level variability in antimicrobial prescribing in 2019. Methods: The RTI case definitions were developed using demographic, diagnostic coding and keywords in electronic medical record. Manual chart abstraction was performed to identify cases of acute otitis media. Remaining RTI definitions were validated using a random sample of 5,164 patients with encounters in 2019. The proportion of patients with an RTI treated with antibiotics was determined by provider, per patient, per episode and per patient encounter. Results: Negative predictive value, positive predictive value and prevalence were as follows: 1.00 (0.99-1.00), 0.99 (0.96-0.99) and 4.14% (4.10-4.19) for common cold; 1.00 (0.99-1.00), 0.94 (0.88-0.98) and 1.09% (1.07-1.12) for acute otitis media; 0.98 (0.96-1.00), 0.93 (0.87-0.97) and 1.2% (1.18-1.22) for acute pharyngitis; 0.99 (0.99-1.00), 0.88 (0.81-0.93) and 1.99% (1.96-2.02) for sinusitis; 0.99 (0.97-0.99), 0.95 (0.89-0.98) and 4.01% (3.97-4.05) for acute bronchitis/asthma. By provider, median (interquartile range [IQR]) proportion treated with antibiotics (per patient) was 6.72 (14.92) for common cold, 64.29 (40.00) for acute otitis media, 20.00 (38.89) for pharyngitis, 54.17 (38.09) for sinusitis, 8.33 (20.00) for acute bronchitis/asthma and 21.10 (20.56) for overall RTI. Conclusion: The CPCSSN can provide national surveillance of antimicrobial prescribing practices for RTI across primary care. Baseline variability underscores the need for provider feedback and quality improvement.

Indexed as

antimicrobial stewardshipaudit and feedbackprimary carerespiratory tract infectionvalidation

Identifiers

PMID35480706
PMCPMC9017799
OpenAlexW4223484243

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.